Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Wisconsin, Madison
University of Miami
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC